Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Could I retire early with a FTSE 100 portfolio led by female CEOs?

There are only five FTSE 100 companies run by female CEOs. Here’s why I think they could make a great core retirement portfolio.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Did you know only five companies in the FTSE 100 are headed by female CEOs? According to data from IG.com, the current growth rate suggests it’s going to take until the year 2101 to achieve a 50/50 balance. And there’s a big pay gap too. The top-paid male boss is Ocado‘s Tim Steiner. He’s on a total package worth around 10 times that of the top female CEO, Emma Walmsley of GlaxoSmithKline.

Source: IG.com

Gender stereotypes?

Is it down to gender stereotypes? Which image of a boss do you think works best for, say, a top bank? The aggressive gung-ho Fred ‘The Shred’ Goodwin, whose leadership brought Royal Bank of Scotland to its knees? Or Alison Rose, currently guiding that same bank’s successful recovery (albeit with a coronavirus-led share price hit at the moment)?

During the banking crisis, the cartoons I saw depicted fat cat bankers, invariably as men in braces, with fat cigars and wads of cash. Was that unfair? If you want an insight into the macho male image of finance and investment, I recommend a read of Liar’s Poker by Michael Lewis.

Stereotypes are generally unfair. Obviously we want our top companies to be run by the very best people, regardless of gender. For example, I rate Glaxo’s Emma Walmsley and AstraZeneca‘s Pascal Soriot as two of our top CEOs, both running excellent companies with long-term focus.

How would a small portfolio of only those five companies run by female bosses look? GlaxoSmithKline, yes. I’m a long-term bull when it comes to the UK’s top pharmaceuticals firms. And my admiration for the progress made at RBS has led me to rate the bank as a buy for some time. RBS is riskier now. But the shares are cheaper than they’ve been for a long time. And I’m upbeat about the long-term potential.

Female CEOs

Carolyn McCall’s ITV is next. I’ve not been a great fan of the company. But my negativity has been largely tied to its dividend, which I’ve seen as excessive amid a time of earnings pressure. It’s now suspended the 2019 final dividend, and has withdrawn 2020 dividend plans. In the light of that, and the virus crash, I think the shares look oversold.

Whitbread, headed by Alison Brittain, is another whose share price has nosedived during the health crisis. We’re looking at a fall of a shade under 50%. I think Whitbread has a strong enough balance sheet to survive the crisis. But I can’t help thinking the dividend should be withdrawn in the short term.

Finally, one of my favourite cash cows is Severn Trent. Headed by Liv Garfield, Severn Trent has the disadvantage of operating in a regulated business. But against that, it has a very clear view of its long-term income and pays one of the most reliable dividends on the market. Its shares are down 24%, and I think that’s unfair for such a defensive stock.

I rate these companies as well above the median in terms of quality of management. And if you buy all five and hold them for the long term (by which I mean at least five years, preferably 10, or more), I reckon you’d be looking at a well-diversified start to a FTSE 100 retirement portfolio.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca and ITV. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The BP share price could face a brutal reckoning in 2026

Harvey Jones is worried about the outlook for the BP share price, as the global economy struggles and experts warn…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

How on earth did Lloyds shares explode 75% in 2025?

Harvey Jones has been pleasantly surprised by the blistering performance of Lloyds shares over the last year or two. Will…

Read more »

Group of four young adults toasting with Flying Horse cans in Brazil
Investing Articles

Down 56% with a 4.8% yield and P/E of 13 – are Diageo shares a generational bargain?

When Harvey Jones bought Diageo shares he never dreamed they'd perform this badly. Now he's wondering if they're just too…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Could these 3 holdings in my Stocks and Shares ISA really increase in value by 25% in 2026?

James Beard’s been looking at the 12-month share price forecasts for some of the positions in his Stocks and Shares…

Read more »

National Grid engineers at a substation
Investing Articles

2 reasons I‘m not touching National Grid shares with a bargepole!

Many private investors like the passive income prospects they see in National Grid shares. So why does our writer not…

Read more »

Number 5 foil balloon and gold confetti on black.
Investing Articles

£10,000 invested in Greggs shares 5 years ago would have generated this much in dividends…

Those who invested in Greggs shares five years ago have seen little share price growth. However, the dividends have been…

Read more »

Rolls-Royce Hydrogen Test Rig at Loughborough University
Growth Shares

Here is the Rolls-Royce share price performance for 2023, 2024, and 2025

Where will the Rolls-Royce share price be at the end of 2026? Looking at previous years might help us find…

Read more »

Investing Articles

This FTSE 250 stock could rocket 49%, say brokers

Ben McPoland takes a closer look at a market-leading FTSE 250 company that generates plenty of cash and has begun…

Read more »